Centessa Pharmaceuticals (CNTA) Change in Cash (2020 - 2026)

Centessa Pharmaceuticals (CNTA) has 7 years of Change in Cash data on file, last reported at $1.1 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $1.1 million, up 100.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$42.1 million (down 222.09% YoY), and the FY2025 annual result was -$321.3 million, down 225.89% from the prior year.
• Change in Cash declined to $1.1 million in Q1 2026 per CNTA's latest filing, from $11.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $267.7 million in Q3 2024 and troughed at -$278.1 million in Q1 2025.
• A 5-year average of -$31.3 million and a median of -$39.3 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2024 and 2025: Change in Cash surged 918.55% in 2024, then sank 2733.93% in 2025.
• A 5-year view of Change in Cash shows it stood at -$51.2 million in 2022, then rose by 15.1% to -$43.5 million in 2023, then soared by 72.84% to -$11.8 million in 2024, then soared by 194.38% to $11.1 million in 2025, then sank by 89.84% to $1.1 million in 2026.
• Business Quant data shows CNTA's Change in Cash at $1.1 million in Q1 2026, $11.1 million in Q4 2025, and $6.6 million in Q3 2025.